Consumer Groups Urge Congress to Take Action to Address Big Drug Company Abuse of the Patent System
11.16.2026
Families USA joined 14 consumer advocate organizations to urge Congress to take action before the end of the year to address big drug companies’ abuse of the patent system. Our organizations have worked state by state to pass and implement policies that take on unaffordable prescription drug costs — including price transparency laws, anti-gouging statutes, and Prescription Drug Affordability Boards (PDABs) with upper payment limits.
Ongoing court litigation against state drug price reforms are using existing patent laws as the basis to undermine reforms to bring down drug costs. If successful, it will convert every federal patent into a shield against state affordability efforts — no matter how excessive drug prices are. States are not attempting to rewrite patent law, they are attempting to protect their residents from prices that are frequently the product of patent abuse, not patent-protected innovation.
The letter calls on Congress to end patent abuse loopholes in order to ensure families in their districts and states and across the country don’t have to pay the price.